<p class="doc-ti" id="d1e39-65-1" style="font-weight: 600; font-style: italic; text-align: center;">COMMISSION IMPLEMENTING DECISION (EU) 2017/1387</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">of 24 July 2017</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;"> <span class="sp-normal"> <span class="italic">(notified under document C(2017) 4975)</span> </span> </p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">(Only the English text is authentic)</p><section><p class="normal">THE EUROPEAN COMMISSION,</p><p class="normal">Having regard to the Treaty on the Functioning of the European Union,</p><p class="normal">Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, and in particular Article 7(1) thereof,</p><p class="normal">Whereas:</p><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(1)</p> </td> <td valign="top"> <p class="normal">On 13 June 2012, the company DSM Food Specialties made a request to the competent authorities of France to place an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span>, on the Union market as a novel food ingredient within the meaning of point (d) of Article 1(2) of Regulation (EC) No 258/97. The target population is the general adult population.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(2)</p> </td> <td valign="top"> <p class="normal">On 31 July 2014, the competent food assessment body of France issued its initial assessment report. In that report it came to the conclusion that an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> meets the criteria for novel food ingredient set out in Article 3(1) of Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(3)</p> </td> <td valign="top"> <p class="normal">On 11 November 2014, the Commission forwarded the initial assessment report to the other Member States.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(4)</p> </td> <td valign="top"> <p class="normal">Reasoned objections were raised by other Member States within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(5)</p> </td> <td valign="top"> <p class="normal">On 25 November 2015, the Commission consulted the European Food Safety Authority (EFSA) asking it to carry out an additional assessment for an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> as a novel food ingredient in accordance with Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(6)</p> </td> <td valign="top"> <p class="normal">On 13 December 2016, EFSA in its opinion on the safety of prolyl oligopeptidase as a novel food ingredient pursuant to Regulation (EC) No 258/97 concluded that the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> is safe for the proposed use and use levels.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(7)</p> </td> <td valign="top"> <p class="normal">That opinion gives sufficient grounds to establish that the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> in the proposed use and use levels complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(8)</p> </td> <td valign="top"> <p class="normal">Enzyme preparation of prolyl oligopeptidase falls outside the scope of Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed as the genetically modified strain of <span class="italic">Aspergillus niger</span> is used as a processing aid and the material derived from the genetically modified microorganism is not present in the novel food.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(9)</p> </td> <td valign="top"> <p class="normal">Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements. The use of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> should be authorised without prejudice to the provisions of that Directive.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(10)</p> </td> <td valign="top"> <p class="normal">The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,</p> </td> </tr> </tbody> </table><p class="normal">HAS ADOPTED THIS DECISION:</p></section> <section><p class="ti-art" id="d1e205-65-1" style="font-style: italic; text-align: center;">Article 1</p><p class="normal">Without prejudice to Directive 2002/46/EC, the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> as specified in Annex I to this Decision may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general adult population with a maximum dose established in Annex II to this Decision.</p></section> <section><p class="ti-art" id="d1e213-65-1" style="font-style: italic; text-align: center;">Article 2</p><p class="normal">The designation of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of <span class="italic">Aspergillus niger</span> authorised by this Decision on the labelling of the foodstuffs shall be ‘prolyl oligopeptidase’.</p></section> <section><p class="ti-art" id="d1e225-65-1" style="font-style: italic; text-align: center;">Article 3</p><p class="normal">This Decision is addressed to DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</p></section>